The Hyperglycemia and Adverse Pregnancy Outcome Study

Diabetes Care - Tập 35 Số 4 - Trang 780-786 - 2012
Patrick M. Catalano1, David McIntyre2, J. CRUICKSHANK3,4, David R. McCance5, Alan Dyer6, Boyd E. Metzger7, Lynn P. Lowe6, Elisabeth R. Trimble8, Donald R. Coustan9, Bengt Persson10, Moshe Hod11, Jeremy Oats12
1Reproductive Biology, Case Western Reserve University at MetroHealth Medical Center, Cleveland, Ohio, USA.
2Endocrinology and Obstetric Medicine, Mater Medical Research Institute, University of Queensland, Brisbane, Australia
3Diabetes and Clinical Endocrinology, University of Manchester and Royal Infirmary, Manchester, U.K.
4Nutritional Sciences
5Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, Northern Ireland, U.K.
6Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
7Division of Endocrinology Metabolism and Molecular Medicine, Northwestern University Feinberg, School of Medicine, Chicago, Illinois
8Department of Clinical Biochemistry, Queen’s University Belfast, Belfast, Northern Ireland, U.K.
9Division of Maternal Fetal Medicine, Women & Infants’ Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence, Rhode Island
10Department of Pediatrics, Karolinska Institute, Stockholm, Sweden
11Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Rabin Medical Center-Sackler Faculty of Medicine, Tel-Aviv University, Petah-Tiqva, Israel
12Obstetric Medicine, Mater Misericordiae Mothers’ Hospital-University of Queensland, Brisbane, Australia

Tóm tắt

OBJECTIVE To determine associations of gestational diabetes mellitus (GDM) and obesity with adverse pregnancy outcomes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. RESEARCH DESIGN AND METHODS Participants underwent a 75-g oral glucose tolerance test (OGTT) between 24 and 32 weeks. GDM was diagnosed post hoc using International Association of Diabetes and Pregnancy Study Groups criteria. Neonatal anthropometrics and cord serum C-peptide were measured. Adverse pregnancy outcomes included birth weight, newborn percent body fat, and cord C-peptide >90th percentiles, primary cesarean delivery, preeclampsia, and shoulder dystocia/birth injury. BMI was determined at the OGTT. Multiple logistic regression was used to examine associations of GDM and obesity with outcomes. RESULTS Mean maternal BMI was 27.7, 13.7% were obese (BMI ≥33.0 kg/m2), and GDM was diagnosed in 16.1%. Relative to non-GDM and nonobese women, odds ratio for birth weight >90th percentile for GDM alone was 2.19 (1.93–2.47), for obesity alone 1.73 (1.50–2.00), and for both GDM and obesity 3.62 (3.04–4.32). Results for primary cesarean delivery and preeclampsia and for cord C-peptide and newborn percent body fat >90th percentiles were similar. Odds for birth weight >90th percentile were progressively greater with both higher OGTT glucose and higher maternal BMI. There was a 339-g difference in birth weight for babies of obese GDM women, compared with babies of normal/underweight women (64.2% of all women) with normal glucose based on a composite OGTT measure of fasting plasma glucose and 1- and 2-h plasma glucose values (61.8% of all women). CONCLUSIONS Both maternal GDM and obesity are independently associated with adverse pregnancy outcomes. Their combination has a greater impact than either one alone.

Từ khóa


Tài liệu tham khảo

Owens, 2010, ATLANTIC DIP: the impact of obesity on pregnancy outcome in glucose-tolerant women, Diabetes Care, 33, 577, 10.2337/dc09-0911

Landon, 2011, The relationship between maternal glycemia and perinatal outcome, Obstet Gynecol, 117, 218, 10.1097/AOG.0b013e318203ebe0

World Health Organization, 1999, Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus

Metzger, 2008, Hyperglycemia and adverse pregnancy outcomes, N Engl J Med, 358, 1991, 10.1056/NEJMoa0707943

HAPO Study Cooperative Research Group, 2010, Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index, BJOG, 117, 575, 10.1111/j.1471-0528.2009.02486.x

The HAPO Study Cooperative Research Group, 2010

Boney, 2005, Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus, Pediatrics, 115, e290, 10.1542/peds.2004-1808

Catalano, 2006, The short- and long-term implications of maternal obesity on the mother and her offspring, BJOG, 113, 1126, 10.1111/j.1471-0528.2006.00989.x

Metzger, 2007, Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring, Clin Obstet Gynecol, 50, 972, 10.1097/GRF.0b013e31815a61d6

Metzger, 2010, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy, Diabetes Care, 33, 676, 10.2337/dc10-0719

World Health Organization, 2000, Obesity: preventing and management of global epidemic, World Health Organ Tech Rep Ser, 984, 1

HAPO Study Cooperative Research Group, 2009, Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics, Diabetes, 58, 453, 10.2337/db08-1112

O’Rahilly, 1987, Haemolysis affects insulin but not C-peptide immunoassay, Diabetologia, 30, 394, 10.1007/BF00292540

Brown, 2001, The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP), Hypertens Pregnancy, 20, IX, 10.3109/10641950109152635

Catalano, 1995, Anthropometric estimation of neonatal body composition, Am J Obstet Gynecol, 173, 1176, 10.1016/0002-9378(95)91348-3

American Diabetes Association, 2003, Gestational diabetes mellitus, Diabetes Care, 26, S103, 10.2337/diacare.26.2007.S103

Flegal, 2010, Prevalence and trends in obesity among US adults, 1999-2008, JAMA, 303, 235, 10.1001/jama.2009.2014

Deurenberg, 2001, Universal cut-off BMI points for obesity are not appropriate, Br J Nutr, 85, 135, 10.1079/BJN2000273

WHO Expert Consultation, 2004, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies, Lancet, 363, 157, 10.1016/S0140-6736(03)15268-3

Catalano, 2009, Fetuses of obese mothers develop insulin resistance in utero, Diabetes Care, 32, 1076, 10.2337/dc08-2077

Harmon, 2011, Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth, Diabetes Care, 34, 2198, 10.2337/dc11-0723

Metzger, 1980, Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids, Diabetes Care, 3, 402, 10.2337/diacare.3.3.402

Schaefer-Graf, 2008, Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus, Diabetes Care, 31, 1858, 10.2337/dc08-0039

Catalano, 2011, Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic?, Am J Obstet Gynecol, 204, 479, 10.1016/j.ajog.2010.11.039

Crowther, 2005, Effect of treatment of gestational diabetes mellitus on pregnancy outcomes, N Engl J Med, 352, 2477, 10.1056/NEJMoa042973

Landon, 2009, A multicenter, randomized trial of treatment for mild gestational diabetes, N Engl J Med, 361, 1339, 10.1056/NEJMoa0902430

Rasmussen, 2009, Weight gain during pregnancy: reexamining the recommendations

Thông tin
Thông tin xuất bản

Diabetes Care

Tập 35 Số 4

780-786

Thông tin tác giả